News Focus
News Focus
icon url

DewDiligence

07/12/23 2:39 PM

#247972 RE: DewDiligence #241067

AVRO—(+47%)—ceases clinical development—seeks “strategic alternatives”:

https://www.businesswire.com/news/home/20230712243011/en